Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Professor Leigh Ackland (left), Director of Deakin's Centre for Cellular and Molecular Biology, and Deputy Director of the Molecular and Medical Research SRC and Ms Bronwyn Halfpenny (right), Victorian Government Health Ambassador for Diabetes. Credit: Deakin University

Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

Scientists at Deakin University have discovered that specific epigenetic markers can distinguish with who develop type 2 diabetes from women with gestational diabetes who do not develop type 2 diabetes after pregnancy.

Gestational diabetes is increasing significantly in Australia. Its incidence has almost doubled since 2013 – increasing by eight per cent during 2016.

"In the past year in Australia over 37,000 women were diagnosed with gestational diabetes, that's 103 women every day," said project leader Professor Leigh Ackland, Director of Deakin's Centre for Cellular and Molecular Biology, and Deputy Director of the Molecular and Medical Research SRC.

"Gestational diabetes is a strong population predictor of subsequent development of type 2 diabetes, with a greater than seven-fold increase in risk of development of type 2 diabetes, compared with women with normal in pregnancy," Professor Ackland said.

A Deakin team, with colleagues from several other universities, tested 39 Australian women in the late stages of pregnancy for glucose intolerance and Type 2 diabetes – retesting the women at 20 weeks post-partem. In women with gestational diabetes, different epigenetic profiles were found in the group of women who developed type 2 diabetes, compared with women who did not.

The Victorian Government Health Ambassador for Diabetes, Ms Bronwyn Halfpenny, recently visited Deakin's Centre for Cellular and Molecular Biology, and the Molecular and Medical Research Strategic Research Centre (SRC) to learn about the research. Ms Halfpenny is Member for Thomastown and Government Whip in the Victorian Legislative Assembly.

"It is wonderful to learn about the science behind diabetes," Ms Halfpenny said. "I am very interested in the potential of this research. It's particularly exciting that we can target specific groups – as a much better way of allocating our resources."

Professor Ackland explained that women with a history of gestational diabetes are at increased risk of cardiovascular disease and their offspring are at increased risk of metabolic syndrome, diabetes and cardiovascular disease.

Professor Trish Livingston, Associate Dean (Research) in the Faculty of Health, explained that the new field of epigenetics has outstanding potential for progressing health treatment in many areas. Made possible by sophisticated analytic technology such as 3-D imaging and genome sequencing, it addresses changes in organisms caused by modification of gene expression, rather than alteration of the genetic code itself.

"Epigenetics shows us how environmental factors can affect the human body and can change our physiology," said Professor Livingston. "The changes to gene expression can be transmitted across generations."

Professor Ackland noted that, until now, epigenetics has been more of a lab-based science.

"It hasn't been taken up previously in public health areas like gestational diabetes, but it has huge potential," she said.

The Deakin researchers are currently seeking funding to develop the next research phase as a collaborative project across Victorian regions with health providers such as Western Health and Monash Health, to validate their study on a larger scale over a five-year, post-partum period.

They hope the new study will enable them to develop a predictive test – allowing lifestyle interventions to more effectively target at-risk women. It would also show if epigenetic changes can be reversed by treatment such as diet and exercise, and reveal epigenetic differences across ethnic groups.

The Associate Director of the Global Obesity Centre at Deakin, Professor Anna Peeters, explained that the overweight and obesity epidemic is a major cause of the increase in the national incidence of diabetes, amongst other conditions like heart disease.

"This epidemic is creating a huge burden of future disease for Australia. In 1980, when we began collecting obesity-related data, one in ten Australian adults were overweight or obese," said Professor Peeters.

"Now, almost 30 per cent of Australian adults fit that category, but the distribution is not equal. In poorer neighbourhoods as many as 40 per cent of adults can be overweight or obese. Indigenous Australians are particularly at risk.

"However, we have very good data about the success of interventions, which can reduce the incidence of diabetes by 50 per cent. It is clearly more cost effective to intervene with those at highest risk."

Professor Bodil Rasmussen, Chair in Nursing (Western Health) added: "Over time, people may revert to their older habits, but even delaying the onset of a few years would give individuals better chances of having a longer life."

Explore further: Diabetes linked to changes in gene behaviour driven by environment

More information: Agnes A. Michalczyk et al. Epigenetic Markers to Predict Conversion From Gestational Diabetes to Type 2 Diabetes, The Journal of Clinical Endocrinology & Metabolism (2016). DOI: 10.1210/jc.2015-4206

Related Stories

Diabetes linked to changes in gene behaviour driven by environment

May 17, 2016
Why gestational diabetes leads to type 2 diabetes has baffled medical science for decades, but new research led by Deakin University has shown the answer could be in our genes' ability to change their behaviour due to signals ...

Early periods associated with risk of gestational diabetes

March 6, 2017
The age at which girls start menstruating could flag a later risk of diabetes during pregnancy, according to a University of Queensland study

Healthy diet could decrease gestational diabetes risk for South Asian women

August 10, 2017
South Asian women in Ontario are at high risk for gestational diabetes, but a change in diet and pre-pregnancy weight could make a significant difference, according to a new study from McMaster University.

Even 'healthy' weight gain raises pregnancy diabetes risk

April 4, 2017
University of Queensland School of Public Health researcher Akilew Adane said women who gained more than 2.5 per cent of their body weight each year had almost triple the risk of gestational diabetes compared to women who ...

Pregnancy diet high in refined grains could increase kids' obesity by age 7

June 7, 2017
Children born to women with gestational diabetes whose diet included high proportions of refined grains may have a higher risk of obesity by age 7, compared to children born to women with gestational diabetes who ate low ...

Probiotics may reduce risk of gestational diabetes

April 4, 2017
Research led by the University of Otago, Wellington has found that a 'home-grown' naturally occurring probiotic reduces the risk of developing diabetes during pregnancy (gestational diabetes) and lowers fasting blood sugar.

Recommended for you

Pancreatic islets study may spur diabetes treatment advances

September 22, 2017
Investigators in the Vanderbilt Diabetes Research and Training Center (VDRTC) and collaborators at Stanford University have discovered new insights into the molecular mechanisms of cell proliferation in juvenile human pancreatic ...

Finding a natural defense against clogged arteries

September 20, 2017
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective ...

Study identifies blood vessel as a therapeutic target for diabetes

September 14, 2017
Blood vessels have an often overlooked role of regulating the transfer of nutrients from the blood to organs in the body. In a new Yale-led study, researchers have identified a role of a secreted protein, apelin, in regulating ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Could swine flu be linked to type 1 diabetes?

September 14, 2017
(HealthDay)—Young people who've been infected with the H1N1 swine flu virus may be at increased risk for type 1 diabetes, a new study suggests.

Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.